Molecular Characterization of Biofilm-related Virulence and Resistance genes in Candida albicans Isolates from Women with Vulvovaginitis

Solhan Mustafa Ahmadessa; Solaf Jawhar Ali

doi:10.24017/science.2025.2.6

Authors

Solhan Mustafa Ahmadessa Department of Medical Laboratory, Technical Institute of Sulaimani, Sulaimani Polytechnic University, Sulaymaniyah, Iraq https://orcid.org/0009-0007-5369-5087
Solaf Jawhar Ali Department of Medical Laboratory, College of Health and Medical Technology, Sulaimani Polytechnic University, Sulaymaniyah, Iraq https://orcid.org/0009-0004-6324-8473

Abstract

One of the most prevalent reasons for gynecologic consultations is vulvovaginitis (VV), particularly vulvovaginal candidiasis (VVC). The etiology of VVC mostly associated with Candida albicans (C. albicans). The recurrence of VVs and the development of resistance to antimicrobials, along with efforts to find therapeutic alternatives are of paramount importance. Thus, this study aims to find the prevalence C. albicans virulence, resistance genes in addition to its susceptibility to antifungals. In this case control study, a total of 125 high vaginal cotton swabs attained in duplicate. from 100 wome clinically diagnosed with VVC and 25 controls (non-VVC). C. albicans was isolated with Hicrome differential agar and confirmed with species-specific primers using Polymerase chain reaction. Genes of the studied virulence determinants, Aglutinin-Like-Sequence (ALS1, ALS3), Hyphal Wall Protein1 (HWP1) as well as resistance determinants associated such as multidrug-resistance (MDR1) and Candida drug resistance (CDR1, CDR2) were also tested. The prevalence of Candida species were 70% and 32% in case and control groups, respectively. Further, the frequency of C. albicans were 88.57% (case group) and 100% (control group). The most common virulence gene was ALS3, present in 96.7% of case group and 87.5% of control group. Additionally, the results indicated that 98.39% of case group and 100% of control group exhibited MDR1 and CDR2 from confirmed isolates of C. albicans. Lastly, the result showed the highest antifungal resistance rates in case group were against voriconazole (70.97%) and fluconazole (40.32%), whereas in control the antifungal resistance was 75% for both voriconazole and fluconazole. In conclusion, high rate of virulence and resistance genes amongst women with VVC and therefore, the study suggests the importance of these genes to be targeted in new antifungal drugs.

Keywords:

Vulvovaginitis, C. albicans, Agglutinin-like sequence, Hyphal wall protein, Multi-drug resistance, antifungal susceptibility

References

S. Lamsal et al., “Antifungal susceptibility and biofilm formation of candida albicans isolated from different clinical specimens,” Tribhuvan University Journal of Microbiology, pp. 53–62, Dec. 2021, doi: 10.3126/tujm.v8i1.41195. DOI: https://doi.org/10.3126/tujm.v8i1.41195

P. Nyirjesy, C. Brookhart, G. Lazenby, J. Schwebke, and J. D. Sobel, “Vulvovaginal candidiasis: a review of the evidence for the 2021 centers for disease control and prevention of sexually transmitted infections treatment guidelines,” Clinical Infectious Diseases, vol. 74, no. Supplement_2, pp. S162–S168, Apr. 2022, doi: 10.1093/cid/ciab1057. DOI: https://doi.org/10.1093/cid/ciab1057

L. Mtibaa et al., “Les candidoses vulvovaginales: etiologies, symptomes et facteurs de risque,” Journal de Mycologie Medicale, vol. 27, no. 2, pp. 153–158, 2017, doi: https://doi.org/10.1016/j.mycmed.2017.01.003. DOI: https://doi.org/10.1016/j.mycmed.2017.01.003

D. J. O’Laughlin and R. G. McCoy, “Diabetes and vulvovaginal conditions,” Clinical Diabetes, vol. 41, no. 3, pp. 458–464, 2023, doi: https://doi.org/10.2337/cd23-0011. DOI: https://doi.org/10.2337/cd23-0011

H. M. E. Willems, S. S. Ahmed, J. Liu, Z. Xu, and B. M. Peters, “Vulvovaginal candidiasis: a current understanding and burning questions,” Journal of Fungi, vol. 6, no. 1, p. 27, 2020, doi: https://doi.org/10.3390/jof6010027. DOI: https://doi.org/10.3390/jof6010027

J. D. Sobel, “Vulvovaginal candidosis,” The Lancet, vol. 369, no. 9577, pp. 1961–1971, 2007, doi: DOI:10.1016/S0140-6736(07)60917-9. DOI: https://doi.org/10.1016/S0140-6736(07)60917-9

R. Shrief, M. E. S. Zaki, E. M. El-Sehsah, S. Ghaleb, and M. Mofreh, “Study of antifungal susceptibility, virulence genes and biofilm formation in candida albicans,” The Open Microbiology Journal, vol. 13, no. 1, pp. 241–248, Oct. 2019, doi: 10.2174/1874285801913010241. DOI: https://doi.org/10.2174/1874285801913010241

A. A. Al-Rukeimi, S. M. M. Al-Hatami, D. A. AL-Danany, H. A. Al-Shamahy, and R. A. A. Al Rukeimi, “PREVALENCE and risk factors associated with vulvovaginal candidiasis during pregnancy in sana’a, yemen,” Universal Journal of Pharmaceutical Research, Jul. 2020, doi: 10.22270/ujpr.v5i3.407. DOI: https://doi.org/10.22270/ujpr.v5i3.407

M. Maheronnaghsh, A. Teimoori, P. Dehghan, and M. Fatahinia, “The evaluation of the overexpression of the erg‐11, mdr‐1, cdr‐1, and cdr‐2 genes in fluconazole‐resistant candida albicans isolated from ahvazian cancer patients with oral candidiasis,” Journal of Clinical Laboratory Analysis, vol. 36, no. 2, p. e24208, 2022, doi: https://doi.org/10.1002/jcla.24208. DOI: https://doi.org/10.1002/jcla.24208

A. C. Seña, L. A. Goldstein, G. Ramirez, A. J. Parish, and R. S. McClelland, “Bacterial vaginosis and its association with incident trichomonas vaginalis infections: a systematic review and meta-analysis,” Sexually Transmitted Diseases, vol. 48, no. 12, pp. e192–e201, 2021, doi: DOI:10.1097/OLQ.0000000000001537. DOI: https://doi.org/10.1097/OLQ.0000000000001537

M. Roudbary, S. Roudbarmohammadi, B. Bakhshi, and Z. Farhadi, “Relation of als 1 and als3 genes and fluconazole resistance in candida albicans isolated from vaginal candidacies,” International Journal of Molecular and Clinical Microbiology, vol. 2, no. 2, pp. 170–174, 2012, doi: https://www.researchgate.net/publication/307396916v.

S. H. Ardehali et al., “Molecular detection of als1, als3, hwp1 and sap4 genes in candida genus isolated from hospitalized patients in intensive care unit, tehran, iran,” Cellular and Molecular Biology, vol. 65, no. 4, pp. 15–22, 2019, doi: 10.14715/cmb/2019.65.4.3. DOI: https://doi.org/10.14715/cmb/2019.65.4.3

F. Mohammadi, N. Hemmat, Z. Bajalan, and A. Javadi, “Analysis of biofilm-related genes and antifungal susceptibility pattern of vaginal candida albicans and non- candida albicans species,” BioMed Research International, vol. 2021, 2021, doi: 10.1155/2021/5598907. DOI: https://doi.org/10.1155/2021/5598907

E. Monroy-Pérez et al., “High virulence and antifungal resistance in clinical strains of candida albicans,” Canadian Journal of Infectious Diseases and Medical microbiology, vol. 2016, 2016, doi: 10.1155/2016/5930489. DOI: https://doi.org/10.1155/2016/5930489

H. Du, J. Bing, T. Hu, C. L. Ennis, C. J. Nobile, and G. Huang, “Candida auris: epidemiology, biology, antifungal resistance, and virulence,” PLoS Pathogens, vol. 16, no. 10, p. e1008921, 2020, doi: https://doi.org/10.1371/journal.ppat.1008921. DOI: https://doi.org/10.1371/journal.ppat.1008921

J. de Cássia Orlandi Sardi et al., “Vulvovaginal candidiasis: epidemiology and risk factors, pathogenesis, resistance, and new therapeutic options,” Current Fungal Infection Reports, vol. 15, pp. 32–40, 2021, doi: https://doi.org/10.1007/s12281-021-00415-9. DOI: https://doi.org/10.1007/s12281-021-00415-9

G. Ramage, R. Rajendran, L. Sherry, and C. Williams, “Fungal biofilm resistance,” International Journal of Microbiology, vol. 2012, no. 1, p. 528521, 2012, doi: https://doi.org/10.1155/2012/528521. DOI: https://doi.org/10.1155/2012/528521

S. Tobudic, C. Kratzer, A. Lassnigg, and E. Presterl, “Antifungal susceptibility of candida albicans in biofilms,” Mycoses, vol. 55, no. 3, pp. 199–204, 2012, doi: https://doi.org/10.1111/j.1439-0507.2011.02076.x. DOI: https://doi.org/10.1111/j.1439-0507.2011.02076.x

K. Khosravi Rad, M. Falahati, M. Roudbary, S. Farahyar, and S. Nami, “Overexpression of mdr-1 and cdr-2 genes in fluconazole resistance of candida albicans isolated from patients with vulvovaginal candidiasis,” Current Medical Mycology, vol. 2, no. 4, pp. 24–29, Dec. 2016, doi: 10.18869/acadpub.cmm.2.4.24. DOI: https://doi.org/10.18869/acadpub.cmm.2.4.24

C. Maenchantrarath, P. Khumdee, S. Samosornsuk, N. Mungkornkaew, and W. Samosornsuk, “Investigation of fluconazole susceptibility to candida albicans by maldi-tof ms and real-time pcr for cdr1, cdr2, mdr1 and erg11,” BMC Microbiology, vol. 22, no. 1, p. 153, 2022, doi: https://doi.org/10.1186/s12866-022-02564-4. DOI: https://doi.org/10.1186/s12866-022-02564-4

J. Morschhäuser, “The genetic basis of fluconazole resistance development in candida albicans,” Biochimica et Biophysica Acta (bba)-Molecular Basis of Disease, vol. 1587, no. 2–3, pp. 240–248, 2002, doi: https://doi.org/10.1016/S0925-4439(02)00087-X. DOI: https://doi.org/10.1016/S0925-4439(02)00087-X

A. A. Rahim, S. M. Ahmadissa, L. R. Muhamad, and T. A. Hama Soor, “Antibiotic resistance: current global issue and future challenges,” Microbial Biosystems, vol. 5, no. 2, pp. 29–68, 2021, doi: DOI:10.21608/mb.2021.55637.1029. DOI: https://doi.org/10.21608/mb.2021.55637.1029

P. K. Nigam, “Antifungal drugs and resistance: current concepts,” Our Dermatology Online, vol. 6, no. 2, p. 212, 2015, doi: DOI:10.7241/ourd.20152.58. DOI: https://doi.org/10.7241/ourd.20152.58

D. S. Perlin, R. Rautemaa-Richardson, and A. Alastruey-Izquierdo, “The global problem of antifungal resistance: prevalence, mechanisms, and management,” The Lancet Infectious Diseases, vol. 17, no. 12, pp. e383–e392, 2017, doi: DOI:10.1016/S1473-3099(17)30316-X. DOI: https://doi.org/10.1016/S1473-3099(17)30316-X

E. Esim Buyukbayrak et al., “Diagnosis of vulvovaginitis: comparison of clinical and microbiological diagnosis,” Archives of Gynecology and Obstetrics, vol. 282, no. 5, pp. 515–519, 2010, doi: https://doi.org/10.1007/s00404-010-1498-x. DOI: https://doi.org/10.1007/s00404-010-1498-x

S. Mohammed, K. Shekhany, P. Jalal, and C. Fattah, “Identification and genotyping of candida species involved in oral candidiasis among diabetic patients,” Sulaimani Dental Journal, vol. 9, p. 9, 2022, DOI: https://doi.org/10.17656/sdj.1014. DOI: https://doi.org/10.17656/sdj.10148

M. C. Arendrup, S. Park, S. Brown, M. Pfaller, and D. S. Perlin, “Evaluation of clsi m44-a2 disk diffusion and associated breakpoint testing of caspofungin and micafungin using a well-characterized panel of wild-type and fks hot spot mutant candida isolates,” Antimicrobial Agents and chemotherapy, vol. 55, no. 5, pp. 1891–1895, 2011, doi: https://doi.org/10.1128/aac.01373-10. DOI: https://doi.org/10.1128/AAC.01373-10

H. Wang, Z. Huang, Z. Wu, X. Qi, and D. Lin, “An epidemiological study on vaginitis in 6,150 women of reproductive age in shanghai,” New Microbioligica, vol. 40, no. 2, pp. 113–118, 2017, doi: https://www.newmicrobiologica.org/PUB/allegati_pdf/2017/2/113.pdf.

T. Disha and F. Haque, “Prevalence and risk factors of vulvovaginal candidosis during pregnancy: a review,” Infectious Diseases in Obstetrics and Gynecology, vol. 2022, no. 1, p. 6195712, 2022, doi: https://doi.org/10.1155/2022/6195712. DOI: https://doi.org/10.1155/2022/6195712

B. D. REED, “Risk factors for candida vulvovaginitis,” Obstetrical and Gynecological Survey, vol. 47, no. 8, pp. 551–560, 1992, doi: doi:10.1097/00006254-199208000-00015. DOI: https://doi.org/10.1097/00006254-199208000-00015

H. Y. Xie et al., “Probiotics for vulvovaginal candidiasis in non‐pregnant women,” Cochrane Database of Systematic Reviews, no. 11, 2017, doi: https://doi.org/10.1002/14651858.CD010496.pub2. DOI: https://doi.org/10.1002/14651858.CD010496.pub2

J. M. Achkar and B. C. Fries, “Candida infections of the genitourinary tract,” Clinical microbiology Reviews, vol. 23, no. 2, pp. 253–273, 2010, doi: https://doi.org/10.1128/cmr.00076-09. DOI: https://doi.org/10.1128/CMR.00076-09

G. Bashir, I. Altaf, R. Khurshid, T. Ahmed, A. Ali, and S. Zaffar, “Identification and pattern of antifungal susceptibility of candida species isolated from cases of vaginitis in a tertiary care hospital in india,” Iranian Journal of Microbiology, vol. 15, no. 2, p. 318, 2023, doi: doi:10.18502/ijm.v15i2.12484. DOI: https://doi.org/10.18502/ijm.v15i2.12484

L. S. A. Gunther, H. P. R. Martins, F. Gimenes, A. L. P. de Abreu, M. E. L. Consolaro, and T. I. E. Svidzinski, “Prevalence of candida albicans and non-albicans isolates from vaginal secretions: comparative evaluation of colonization, vaginal candidiasis and recurrent vaginal candidiasis in diabetic and non-diabetic women,” São Paulo Medical Journal, vol. 132, no. 02, pp. 116–120, 2014, doi: https://doi.org/10.1590/1516-3180.2014.1322640. DOI: https://doi.org/10.1590/1516-3180.2014.1322640

S. R. Fan, X. P. Liu, and J. W. Li, “Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of candida species isolates among patients in southern china from 2003 to 2006,” Journal of Obstetrics and Gynaecology Research, vol. 34, no. 4, pp. 561–566, 2008, doi: https://doi.org/10.1111/j.1447-0756.2008.00817.x. DOI: https://doi.org/10.1111/j.1447-0756.2008.00817.x

M. Inci et al., “Investigations of als1 and hwp1 genes in clinical isolates of candida albicans,” Turkish Journal of Medical Sciences, vol. 43, no. 1, pp. 125–130, 2013, doi: 10.3906/sag-1205-90. DOI: https://doi.org/10.3906/sag-1205-90

P. de S. Bonfim-Mendonça et al., “Different expression levels of als and sap genes contribute to recurrent vulvovaginal candidiasis by candida albicans,” Future Microbiology, vol. 16, no. 4, pp. 211–219, 2021, doi: https://doi.org/10.2217/fmb-2020-0059. DOI: https://doi.org/10.2217/fmb-2020-0059

S. Tokak, I. Kiliç, E. Mutlu, F. Beyazyüz, J. Horasanli, and F. Taşbent, “Molecular detection of int, hwp, plb, sap and als genes i̇n candida species isolated from patients with vulvovaginal candidiasisvulvovajinal kandidiyazisli hastalardan i̇zole edilen candida türlerindeki int, hwp, plb, sap ve als genlerinin moleküler tespiti,” Kırıkkale Üniversitesi tıp Fakültesi Dergisithe Journal of Kırıkkale University Faculty of Medicine, 2025, doi: https://doi.org/10.24938/kutfd.1332656. DOI: https://doi.org/10.24938/kutfd.1332656

S. Roudbarmohammadi, M. Roudbary, B. Bakhshi, F. Katiraee, R. Mohammadi, and M. Falahati, “ALS1 and als3 gene expression and biofilm formation in candida albicans isolated from vulvovaginal candidiasis,” Advanced Biomedical Research, vol. 5, no. 1, p. 105, 2016, doi: 10.4103/2277-9175.183666. DOI: https://doi.org/10.4103/2277-9175.183666

P. Dhasarathan et al., “Drug resistance in candida albicans isolates and related changes in the structural domain of mdr1 protein,” Journal of Infection and Public Health, vol. 14, no. 12, pp. 1848–1853, 2021, doi: https://doi.org/10.1016/j.jiph.2021.11.002. DOI: https://doi.org/10.1016/j.jiph.2021.11.002